Alice Baraquin

Conflicts of Interest The authors declare that they have no personal conflict of interests. This study is an extension of the VALGENT (VALidation of HPV GENotyping tests) project in the framework of validating new HPV assays [8]. VALGENT is an independent researcher-induced research project where manufacturers can have their HPV assays evaluated, under the condition that they provide equipment, kits and cover costs for laboratory work and statistical analysis.

CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. REFERENCES 1, , , . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4): 664-670. doi:10.1002/ijc.30716 2, , , et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016; 2:16086. doi:10.1038/nrdp.2016.86 3, , . International standardization and classification of human papillomavirus types. Virology. 2015; 476: 341-344.

CHIMUST Chinese multicenter screening trial CI confidence interval CIN cervical intraepithelial neoplasia grade Ct cycle threshold HPV human papillomavirus HR high risk NC negative control PC positive control PCR polymerase chain reaction qPCR quantitative polymerase chain reaction WHO World Health Organization κ Cohen's kappa 1 BACKGROUND Worldwide, cervical cancer (CC) is the fourth most common cancer among women.1-4 More than 600 000 new cases and >300 000 deaths were estimated in 2020.5-7...